Search research articles
Contact Us
Filters
Showing results (231-240 of 237) with videos related to
Page
of 24
Sort By:
You have reached the last page of results.
This site can display upto 237 results.
Molecular Pharmaceutics
|
April 11, 2024
Physiologically Based Biopharmaceutics Modeling (PBBM): Best Practices for Drug Product Quality, Regulatory and Industry Perspectives: 2023 Workshop Summary Report
Claire Mackie, Sumit Arora, Paul Seo, et al.
Pharmaceutics
|
May 27, 2026
Physiologically Based Biopharmaceutics Modelling-Best Scientific Practices to Define Drug Product Performance, Latest Regulatory and Industry Perspectives: Workshop Summary Report
Mark McAllister, Nena Mistry, Xavier Pepin, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
July 17, 2014
Cytochrome P450 1B1 polymorphisms and risk of renal cell carcinoma in men
Inik Chang, Shinichiro Fukuhara, Darryn K Wong, et al.
Molecular Pharmaceutics
|
April 29, 2025
Development of a Physiologically Based Biopharmaceutics Model Report Template: Considerations for Improved Quality in View of Regulatory Submissions
Sumit Arora, Xavier Pepin, Masoud Jamei, et al.
Molecular Pharmaceutics
|
December 16, 2024
Current State and New Horizons in Applications of Physiologically Based Biopharmaceutics Modeling (PBBM): A Workshop Report
Christer Tannergren, Sumit Arora, Andrew Babiskin, et al.
Molecular Pharmaceutics
|
July 1, 2024
Parameterization of Physiologically Based Biopharmaceutics Models: Workshop Summary Report
Xavier Pepin, Sumit Arora, Luiza Borges, et al.
Molecular Pharmaceutics
|
September 30, 2024
PBBM Considerations for Base Models, Model Validation, and Application Steps: Workshop Summary Report
Tycho Heimbach, Flora Musuamba Tshinanu, Kimberly Raines, et al.
Page
of 24
Search research articles
Search
Showing results (231-240 of 237) with videos related to
Sort By:
Page
of 24
You have reached the last page of results.
This site can display upto 237 results.
Molecular Pharmaceutics
|
April 11, 2024
Physiologically Based Biopharmaceutics Modeling (PBBM): Best Practices for Drug Product Quality, Regulatory and Industry Perspectives: 2023 Workshop Summary Report
Claire Mackie, Sumit Arora, Paul Seo, et al.
Pharmaceutics
|
May 27, 2026
Physiologically Based Biopharmaceutics Modelling-Best Scientific Practices to Define Drug Product Performance, Latest Regulatory and Industry Perspectives: Workshop Summary Report
Mark McAllister, Nena Mistry, Xavier Pepin, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
July 17, 2014
Cytochrome P450 1B1 polymorphisms and risk of renal cell carcinoma in men
Inik Chang, Shinichiro Fukuhara, Darryn K Wong, et al.
Molecular Pharmaceutics
|
April 29, 2025
Development of a Physiologically Based Biopharmaceutics Model Report Template: Considerations for Improved Quality in View of Regulatory Submissions
Sumit Arora, Xavier Pepin, Masoud Jamei, et al.
Molecular Pharmaceutics
|
December 16, 2024
Current State and New Horizons in Applications of Physiologically Based Biopharmaceutics Modeling (PBBM): A Workshop Report
Christer Tannergren, Sumit Arora, Andrew Babiskin, et al.
Molecular Pharmaceutics
|
July 1, 2024
Parameterization of Physiologically Based Biopharmaceutics Models: Workshop Summary Report
Xavier Pepin, Sumit Arora, Luiza Borges, et al.
Molecular Pharmaceutics
|
September 30, 2024
PBBM Considerations for Base Models, Model Validation, and Application Steps: Workshop Summary Report
Tycho Heimbach, Flora Musuamba Tshinanu, Kimberly Raines, et al.
Page
of 24